Apoliprotein E and multiple sclerosis: impact of the epsilon-4 allele on susceptibility,clinical type and progression rate

Abstract

The purpose of this study was to investigate the relation between APOE genotype and Multiple Sclerosis (MS) in a genetically homogeneous population. We examined 240 patients consulting the MS-clinic during a period of 3 years (1996-1999). The mean age of the patients was 41.7 years (range 19-80 Y, SD 10.0 Y). As a measure of the progression rate (PR) the last registered Expanded Disability Status Scale (EDSS) score was divided by the time span (years) from disease onset until the latest assessment. The APOE genotype was determined from saliva and/or blood samples using PCR-techniques. The prevalence of different APOE genotypes was compared with the allele-distribution in a population of 361 persons from a Danish cross-sectional population study. The frequency of APOE-e4/e4 homozygotes was significantly higher in the MS-group as compared to controls (P<0.05, odds ratio: 2.3), whereas the frequency distribution of other genotypes did not differ significantly. The rate of progression was significantly faster in the APOE-e4/e4 homozygotes compared to other genotypes in the MS group (P<0.05). This study suggests that the APOE-e4/e4 homozygotes have an increased risk of developing MS. MS patients with the APOE-e4/e4 allele may also have an increased rate of disease progression.

Keywords

multiple sclerosis apolipoprotein E progression rate susceptibility clinical course

Get full access to this article

View all access options for this article.

References

Shore VG , Shore B. (1973) Biochemistry 12: 502-502 .

Strittmatter WJ et al. (1993) Apolipoprotein E: high avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer's disease . Proc Natl Acad Sci USA 90: 1977-1981 .

Corder EH et al. (1993) Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families . Science 261: 921-931 .

Mayeux R et al. (1993) The apolipoprotein E e4-allele in patients with Alzheimer's disease . Ann Neurol 34: 752-754 .

Saunders AM et al. (1993) Association of Apolipoprotein E e4-allele with late onset and sporadic Alzheimer's disease . Neurology 43: 1467-1472 .

Poirer J et al. (1993) Apolipoprotein E polymorphism and Alzheimer's disease . Lancet 342: 697-699 .

Nalbantoglu J et al. (1994). Predictive value of Apolipo-protein E genotyping in Alzheimer's disease: results of an autopsy series and an analysis of several combined studies . Ann Neurol 36: 899-895 .

Peacock ML , Fink JK. (1994) ApoE e4-allelic association with Alzheimer's disease: independent confirmation using denaturing gradient gel electrophoresis . Neurology 44: 339-341 .

Anwar N et al. (1993) Apolipoprotein E e4-allele and Alzheimer's disease . Lancet 342: 1308-1309 .

10.

Czech C et al. (1993) Apolipoprotein E e4-allele and Alzheimer's disease . Lancet 342: 1309-1310 .

11.

Lucotte G et al. (1993) Apolipoprotein E e4-allele and Alzheimer's disease . Lancet 342: 1309-1309 .

12.

Dal Forno G et al. (1996) Apolipoprotein E Genotype and Rate of Decline in Probable Alzheimer's Disease . Arch Neurol 53: 345-350 .

13.

Jersild C et al. (1973) Histocompatibility determinants in multiple sclerosis, with special reference to clinical course . Lancet 2: 1221-1225 .

14.

Haines JL et al. (1998) Linkage of the MHC to familial sclerosis suggests genetic heterogeneity. The Multiple Sclerosis Genetics Group . Hum Mol Genet 7: 1229-1234 .

15.

Coraddu F et al. (1998) HLA typing in the United Kingdom multiple sclerosis genome screen . Neurogenetics 2: 24-33 .

16.

Sawcer S et al. (1996) A genome screen in multiple sclerosis reveals susceptibility loci in chromosome 6p21 and 17q22 . Nature Genet 13: 464-468 .

17.

Nature Genet 13: 469-471 .

18.

Ebers GC et al. (1996) A full genome search in multiple sclerosis . Nature Genet 13: 472-476 .

19.

Kuokkanen S et al. (1997) Genome wide scan of multiple sclerosis in Finnish multiplex families . Am J Genet 61: 1379-1387 .

20.

Barcellos LF et al. (1997) Chromosome 19 single-locus and multilocus haplotype associations with multiple sclerosis. Evidence of a new susceptibility locus in Caucasian and Chinese patients . JAMA 278: 1282-1283 .

21.

Poirer J. (1994) Apolipoprotein E in animal models of CNS injury and in Alzheimer's disease . TINS 17: 525-530 .

22.

Rifai N et al. (1987) Changes in cerebrospinal fluid IgG and Apolipoprotein E indices in patients with multiple sclerosis during demyelination and remyelination . Clin Chem 33: 1155-1157 .

23.

Kurtzke J. (1983) Rating neurological impairment in multiple sclerosis: An expanded disability status scale (EDSS) . Neurology 33: 1444-1452 .

24.

Hagerup L , Hansen PF. (1968) An investigation of 50-year old persons in Glostrup 1964-1965 . Ugeskr Laeger 130: 1145-1148 .

25.

Main BF et al. (1991) Apolipoprotein E genotyping using the polymerase chain reaction and allele-specific oligo-nucleotide primers . J Lipid Res 32: 183-187 .

26.

Miller SA , Dykes DD , Polesky HF. (1988) A simple salting out procedure for extracting DNA from human nucleated cells . Nucl Acids Res 16: 1215-1215 .

27.

Wenham PR , Price WH , Blandell G. (1991) Apolipoprotein E genotyping by one-stage PCR . Lancet 337: 1158-1159 .

28.

Teasdale TW et al. (2000) Apolipoprotein E and subjective symptomatology following brain injury rehabilitation . Neuropsych Rehabil in press.

29.

Weinshenker BG et al. (1989) The natural history of multiple sclerosis: a geographically based study. 2. Predictive value of the early clinical course . Brain 112: 1419-1428 .

30.

Gerdes LU et al. (1992) Apolipoprotein E polymorphism in a Danish population compared to findings in 45 other study populations around the world . Genet Epidemiol 9: 155-167 .

31.

Rubinsztein DC et al. (1994) ApoE genotypes in multiple sclerosis, Parkinson's disease, schwannomas and late-onset Alzheimer's disease . Moll Cell Probes 8: 519-525 .

32.

Gervais A et al. (1998) Apolipoprotein E polymorphism in multiple sclerosis . Ann Clin Biochem 35: 135-136 .

33.

Evangelou N et al. (1999) Association of the APOE e4 allele with disease activity in multiple sclerosis . JNeurol Neurosurg Psychiatry 67: 203-205 .

34.

Sylantiev C et al. (1998) The APOE 4 allele and progression of disability in multiple sclerosis . Neurology 50: A150-A150 .